Related Experiment Videos
BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control
A L Shaffer1, X Yu, Y He
1Metabolism Branch, Division of Clinical Sciences, National Cancer Institute, Bethesda, Maryland 20892, USA.
Immunity
|September 12, 2000
Summary
The transcriptional repressor BCL-6 controls B cell differentiation and inflammation. Inhibiting BCL-6 promotes plasma cell differentiation, suggesting its role in lymphoma development by blocking differentiation and promoting proliferation.
Area of Science:
- Molecular Biology
- Immunology
- Cancer Research
Background:
- BCL-6 is a transcriptional repressor implicated in lymphomas.
- It plays a role in germinal center B cell differentiation and inflammation.
Purpose of the Study:
- To identify genes regulated by BCL-6.
- To understand BCL-6's role in B cell signaling, inflammation, and differentiation.
Main Methods:
- DNA microarray screening to identify BCL-6 repressed genes.
- Analysis of BCL-6 target genes, including Blimp-1, MIP-1alpha, and IP-10.
- Functional inhibition of BCL-6 to observe effects on cell differentiation markers.
Main Results:
- BCL-6 represses lymphocyte activation genes, modulating B cell receptor signals.
- BCL-6 represses chemokine genes MIP-1alpha and IP-10, potentially reducing inflammation.
- BCL-6 represses Blimp-1, a key factor in plasmacytic differentiation.
- Inhibition of BCL-6 leads to plasmacytic differentiation markers (decreased c-Myc, increased p27kip1).
Conclusions:
- BCL-6 regulates B cell differentiation and inflammatory responses.
- Malignant transformation by BCL-6 may involve inhibiting differentiation and promoting proliferation.
- Targeting BCL-6 could be a strategy for lymphoma treatment.